Cambria Investment Management L.P. Sells 1,957 Shares of Cigna Group $CI

Cambria Investment Management L.P. cut its holdings in Cigna Group (NYSE:CI) by 6.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 28,590 shares of the health services provider’s stock after selling 1,957 shares during the quarter. Cambria Investment Management L.P.’s holdings in Cigna Group were worth $8,241,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Harbor Capital Advisors Inc. lifted its stake in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares during the last quarter. Collier Financial bought a new stake in Cigna Group in the third quarter worth $34,000. Traub Capital Management LLC acquired a new position in Cigna Group during the second quarter worth $48,000. Founders Capital Management raised its holdings in Cigna Group by 53.0% during the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock valued at $44,000 after buying an additional 53 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Cigna Group during the second quarter valued at about $52,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

CI opened at $264.87 on Thursday. The stock’s 50 day simple moving average is $278.57 and its 200-day simple moving average is $282.09. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock has a market cap of $69.80 billion, a PE ratio of 11.94, a P/E/G ratio of 0.91 and a beta of 0.27. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the business earned $6.64 earnings per share. Cigna Group’s quarterly revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is 28.13%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Robert W. Baird decreased their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research note on Thursday, December 11th. Royal Bank Of Canada cut their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. Zacks Research raised Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Guggenheim reiterated a “buy” rating and set a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. Finally, Truist Financial lifted their price target on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $333.11.

Insider Activity

In related news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is currently owned by insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.